Menu Search
Equities

Fusen Pharmaceutical Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
1652:HKG.HS

Fusen Pharmaceutical Co Ltd

Actions
  • Price (HKD)0.93
  • Today's Change0.00 / 0.00%
  • Shares traded310.00k
  • 1 Year change+144.74%
  • Beta0.2879
Data delayed at least 15 minutes, as of Feb 16 2026 03:53 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Fusen Pharmaceutical Co Ltd is a company mainly engaged in the cultivation of Chinese herbal medicine, pharmaceutical research and development, and sales. The Company's main business is the sales of Shuanghuanglian Oral Solutions, Shuanghuanglian Injections and other pharmaceutical products. The Company is also engaged in the research, production, and sales of various proprietary Chinese medicine and western medicine products for treating cold, fever, cardiovascular diseases and anemia. The Company mainly conducts business in the domestic market.

  • Revenue in HKD (TTM)272.64m
  • Net income in HKD-197.95m
  • Incorporated2013
  • Employees1.05k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.